SMAD7 and hepatocellular carcinoma: Increased Linc‐smad7 expression and its positive association with poor clinicopathological features and prognosis in HCC patients were observed in the present study, suggesting that Linc‐smad7 may be promising biomarker and may act as a tumour promoter in HCC.